NewLink down 8% after bailing on indoximod in melanoma study [Seeking Alpha]
NEWLINK GENETICS (NLNK)
Last newlink genetics earnings: 2/28 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.linkp.com/investor-relations
Company Research
Source: Seeking Alpha
NewLink down 8% after bailing on indoximod in melanoma studyNewLink Genetics (NASDAQ:NLNK)announces that it will not proceed to the randomization portion of its Phase 1/2 study,Indigo301, assessing lead candidate IDO-inhibitor indoximod, combined with Merck's KEYTRUDA (pembrolizumab) or Bristol-Myers Squibb's Opdivo (nivolumab) in patients with advanced melanoma. The company's decision was heavily influenced by the recent failure of Incyte's IDO-inhibitor epacadostat in melanoma.Shares are down8% premarket .Previously:Incyte's epacadostat flunks late-stage melanoma study (April 6)Previously:NewLink -44%; sets review of clinical programs(April 6)See all stocks on the move »Now read:Biotech Forum: The Week Ahead »
Show less
Read more
Impact Snapshot
Event Time:
NLNK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NLNK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NLNK alerts
High impacting NEWLINK GENETICS news events
Weekly update
A roundup of the hottest topics